Regions
MAIN/REGIONS
regions/
Regions
  1. Americas
  2. Asia & Oceania
  3. Europe
  4. Middle East & Africa
  1. Solutions
  2. Insights
  3. Events
  4. Contact Us
MAIN/search
MAIN/Solutions
Solutions/
SOLUTIONS
  • Life Sciences Solutions
  • Healthcare Solutions
  • Medical Device and Diagnostic
  • U.S. Government
Life Sciences Solutions

Bringing together unparalleled healthcare data, advanced analytics, innovative technologies, and healthcare expertise to create intelligent connections that speed the development and commercialization of innovative medicines to improve patient lives.

Learn More
Life Sciences Solutions
Healthcare Solutions

Accelerate digital innovation to enable smarter decisions that reduce cost, modernize patient and consumer engagement, and improve health outcomes.

Learn More
Healthcare Solutions
Medical Device and Diagnostic Solutions

Your world is unique – and quite different from pharma. In the U.S., decision-making has shifted from individual physicians to integrated networks--GPOs, IDNs and payers. These groups have heightened the focus on proving your solution’s value, demanding outcomes analyses and putting pressure on pricing.

Learn More
Medical Device and Diagnostic Solutions
U.S. Government Solutions

For government agencies and organizations at every level—from federal or national to regional and local—Big Data can have a huge impact on public health.

Learn More
U.S. Government Solutions
MAIN/Insights
Insights/
U.S. PROGRESS POINT

A curation of IQVIA's best thinking on topics and trends driving change, disruption, and progress in the United States healthcare market.

LEARN MORE
U.S. BLOGS

Get the latest insights on our life sciences, healthcare, and medical technology solutions in the United States. Follow our blog today!

LEARN MORE

U.S. INSIGHTS LIBRARY

"Browse our library of insights and thought leadership.

LEARN MORE
MAIN/Events
Events/
ON-DEMAND WEBINARS

Visit our library of on-demand webinars.

LEARN MORE
UPCOMING EVENTS & WEBINARS

View our upcoming events and webinars.

LEARN MORE

FEATURED WEBINAR

"Top Issues for Pharma to Watch in 2022 and 2023

WATCH NOW
MAIN/Contact Us
Contact Us/
$name

U.S. Post COVID-19 Scenario Planning

Explore potential scenarios that the U.S. healthcare industry could face post COVID-19, and the strategies for where and how to compete in this evolving landscape.

In these two episodes, Mason Tenaglia, IQVIA’s Vice President of U.S. Thought Leadership, will explore four scenarios that have been developed based on a robust exercise conducted by IQVIA U.S. experts. He will also discuss the implications of each scenario for U.S. business and care delivery models over the next 18-24 months.

Locations United States COVID-19 Resources - United States COVID 19 Podcast Series

Episode 1

COVID-19 will have a lasting impact on U.S. business and care delivery models. In a two-episode series, explore four different scenarios for a post COVID-19 world. In the first of two episodes, learn about the exercise conducted to develop the four scenarios and explore the two high-impact scenarios, The Long Night and Too Many Moving Parts. 

The Long Night: Plans for high impact in the U.S. that would continue beyond the next 18 months with no effective disease management before 2022. 

Too Many Moving Parts: Plans based on the assumption that some COVID-19 impact continues for 18 months or more, but that management options exist for vulnerable or high-priority populations.

To explore the two low-impact scenarios, listen to Scenario planning for a post COVID-19 world (part 2)

Featured speaker: Mason Tenaglia, Vice President, Thought Leadership, IQVIA

 

Episode 2

In the second episode of a two-part series, explore two low-impact scenarios for a post-COVID-19 world, Journey Disrupted and Reputation Reborn.

Journey Disrupted: Plans based on a coordinated national-level healthcare policy that would limit surges in COVID-19 infections and accelerate the reopening of non-urban areas in some states.

Reputation Reborn: Plans based on the idea that the virus would subside or be “under control” by mid-2021 due to effective disease management and therapies.

To explore the two high-impact scenarios, listen to  Scenario planning for a post COVID-19 world (Ep. 1)

Featured speaker: Mason Tenaglia, Vice President, Thought Leadership, IQVIA